Germany Next? Perrigo Applies For Rx-To-OTC Daily Contraceptive Pill Switch
Executive Summary
Perrigo is targeting Germany for its next Rx-to-OTC switch of a daily contraceptive (desogestrel 75μg) after seeing success in the US and UK with Opill and Hana respectively.